Oncology Products Division

The Oncology Products Division conducts the marketing of Biocompatibles’ approved oncology products, supplied from facilities in Farnham, UK. These include Drug-Eluting Bead products which are used in more than 35 countries for the treatment of primary liver cancer (HCC), liver metastases from colorectal cancer, and other cancers. Our distribution partners include AngioDynamics Inc., Terumo Corporation and Eisai Co. Ltd.

Bead Block logoBead Block is an embolic device intended for the purpose of embolising the blood vessels of a variety of hypervascularised tumours and arteriovenous ..

DC Bead logo DC Bead, a Drug-Eluting Bead, is a drug delivery embolisation system, intended to be loaded with a drug for the purpose of treating a variety of ..

LC Bead logo LC Bead is a controlled embolisation system intended for the purpose of embolising the blood vessels of a variety of hypervascularised tumours ..

Precision Bead logo PRECISION Bead, a Drug-Eluting Bead, is a drug delivery embolisation system loaded with doxorubicin intended for the purpose of treating ..

Pipeline logo Biocompatibles Drug-Eluting Bead technology is supported by a comprehensive programme of clinical trials designed to confirm our products'...

Published Literature

Browse a selection of peer review journal articles, abstracts, presentations and more.

FAQs

Browse our Frequently Asked Questions. Answers are available as PDF files to download and keep

Webcasts from CIRSE 2008

 


Advanced Search

 

© 2010 Biocompatibles UK Ltd - All rights reserved - Site map - Terms & conditions - Accessiblity - Help - Glossary